Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse

Neuroscience Letters

Volumn 365, Issue 3, 2004, Pages 157-161

  Wu, Hsiang En ^a   MacDougall, Ryan S ^a   Clithero, Andrew D ^a   Leitermann, Randy J ^a   Terashvili, Maia ^a   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Brain; Conditioned place preference; Endomorphins; Mouse; Opioid; Rewarding effect

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ENDOMORPHIN 1; ENDOMORPHIN 2; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; DOSE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AZOCINES; CONDITIONING, OPERANT; INJECTIONS, INTRAVENTRICULAR; LIGANDS; MALE; MICE; NALTREXONE; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 3042751474     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.093     Document Type: Article

References (22)

1. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495
2. De Vries T.J., Shippenberg T.S. Neural systems underlying opiate addiction. J. Neurosci. 22:2002;3321-3325
3. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., Su W., Emmel D., Bolan E.A., Pasternak G.W. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286:1998;1007-1013
4. Greenwell T.N., Zangen A., Martin-Schild S., Wise R.A., Zadina J.E. Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluorogold injections to the ventral tegmental area. J. Comp. Neurol. 454:2002;320-328
5. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15
6. Hung K., Terashvilli M., Tseng L.F. Endomorphin-1, but not endomorphin-2 increase the release of dopamine from the posterior nucleus accumbens in the rats. Soc. Neurosci. Abstr. 33:2003;890.16
7. 2-endomorphin-2 respectively, attenuate the antinociception induced by endomorphin-1 and endomorphin-2 given intrathecally in the mouse. J. Pharmacol. Exp. Ther. 303:2002;874-879
8. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488
9. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101:1999;129-152
10. Mizoguchi H., Narita M., Nagase H., Tseng L.F. Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming. Regul. Pept. 59:1995;255-259
11. Mizoguchi H., Narita M., Oji D.E., Suganuma C., Nagase H., Sora I., Uhl G.R., Cheng E.Y., Tseng L.F. The μ-opioid receptor gene-dose dependently reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice. Neuroscience. 94:1999;203-207
12. Monory K., Bourin M.-C., Spetea M., Tomooly C., Toth G., Matthes H.W., Kieffer B.L., Hanoune J., Borsodi A. Specific activation of the μ opioid receptor (MOR) by endomorphin-1 and endomorphin-2. Eur. J. Neurosci. 22:2000;577-584
13. Narita M., Ozaki S., Ioka M., Mizoguchi H., Nagase H., Tseng L.F., Suzuki T. Different motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience. 105:2001;213-218
14. Ohsawa M., Mizoguchi M., Narita M., Nagase H., Kampine J.P., Tseng L.F. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 298:2001;592-597
15. Sakurada S., Hayashi T., Yuki M., Fujimura T., Murayama K., Yonezawa A., Sakurada C., Takeshita M., Zadina J.E., Kastin A.J. Different antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res. 881:2000;1-8
16. Shippenberg T.S., Elmer G.I. The neurobiology of opiate reinforcement. Crit. Rev. Neurobiol. 14:1998;267-303
17. M. Terashvili, H. Wu, R.J. Leitermann, K. Hung, A.D. Clitero, E.T. Schwasinger, L.F. Tseng, Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat, J. Pharmacol. Exp. Ther. (in press).
18. Tseng L.F., Collins K.A. Spinal involvement of both dynorphin A and met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. J. Pharmacol. Exp. Ther. 266:1993;1430-1438
19. Tseng L.F., Narita M., Suganuma C., Mizoguchi M., Ohsawa M., Nagase H., Kampine J.P. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 292:2000;576-583
20. Wu H., Mizoguchi H., Terashvili M., Leitermann R.J., Hung K., Fujimoto J.M., Tseng L.F. Spinal pretreatment with antisense oligodexoynucleotides against exon-1, -4, -8 of μ-opioid receptor clone leads to differential loss of spinal endomorphin-1- and endomorphin-2-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 303:2002;867-873
21. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ-opioid receptor. Nature. 386:1997;499-502
22. Zangen A., Ikemoto S., Zadina J.E., Wise R.A. Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J. Neurosci. 22:2002;7225-7233